Immunic (IMUX) Short Interest Ratio & Short Volume

$1.52

+0.03 (+2.01%)

(As of 09/13/2024 ET)

Immunic Short Interest Data

Immunic (IMUX) has a short interest of 2.33 million shares. This marks a -7.54% decrease in short interest from the previous month. The short interest ratio (days to cover) is 7.6, indicating that it would take 7.6 days of the average trading volume of 263,220 shares to cover all short positions.

Current Short Interest: 2,330,000 shares
Previous Short Interest: 2,520,000 shares
Change Vs. Previous Month: -7.54%
Dollar Volume Sold Short: $3.52 million
Short Interest Ratio: 7.6 Days to Cover
Last Record Date: August 31, 2024

Outstanding Shares: 90,080,000 shares
Percentage of Shares Shorted: 2.59%
Today's Trading Volume: 349,104 shares
Average Trading Volume: 263,220 shares
Today's Volume Vs. Average: 133%

Short Selling Immunic?

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Short Interest Chart Days to Cover Chart Short Percent of Float Chart

IMUX Short Interest Over Time

IMUX Days to Cover Over Time

IMUX Percentage of Float Shorted Over Time

Ad Paradigm Press

Man who Predicted Trump 2016 Win: “Prepare for Election Meltdown”

Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… A predicted Trump would win. You won’t believe what he’s predicting now.

Click here to see it because it’s a SHOCKER…

Immunic Short Interest History

Export to Excel

Report Date	Total Shares Sold Short	Dollar Volume Sold Short	Change from Previous Report	Percentage of Float Shorted	Days to Cover	Price on Report Date
8/31/2024	2,330,000 shares	$3.52 million	-7.5%	N/A	7.6	$1.51
8/15/2024	2,520,000 shares	$3.40 million	-6.3%	N/A	8.7	$1.35
7/31/2024	2,690,000 shares	$3.85 million	-8.8%	N/A	9.4	$1.43
7/15/2024	2,950,000 shares	$4.01 million	-2.0%	N/A	10.7	$1.36
6/30/2024	3,010,000 shares	$3.34 million	+1.7%	N/A	11.8	$1.11
6/15/2024	2,960,000 shares	$3.52 million	-22.1%	N/A	12.5	$1.19
Get the Latest News and Ratings for IMUX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Immunic and its competitors with MarketBeat's FREE daily newsletter.
5/31/2024	3,800,000 shares	$4.71 million	+34.8%	N/A	13.6	$1.24
5/15/2024	2,820,000 shares	$3.65 million	No Change	N/A	7.2	$1.30
4/30/2024	2,820,000 shares	$3.55 million	-2.1%	N/A	5.7	$1.26
4/15/2024	2,880,000 shares	$3.77 million	-5.0%	N/A	4.9	$1.31
3/31/2024	3,030,000 shares	$4.00 million	+22.7%	N/A	3.1	$1.32
3/15/2024	2,470,000 shares	$3.24 million	+11.3%	N/A	2.5	$1.31
2/29/2024	2,220,000 shares	$3.25 million	-11.9%	N/A	2.4	$1.47
2/15/2024	2,520,000 shares	$3.38 million	-2.7%	N/A	2.9	$1.34
1/31/2024	2,590,000 shares	$3.08 million	-20.6%	N/A	3.3	$1.19
1/15/2024	3,260,000 shares	$4.17 million	+48.2%	N/A	4.2	$1.28
12/31/2023	2,200,000 shares	$3.30 million	-6.4%	N/A	1.9	$1.50
12/15/2023	2,350,000 shares	$3.53 million	-15.2%	N/A	2.9	$1.50
11/30/2023	2,770,000 shares	$3.30 million	-6.4%	N/A	3.5	$1.19
11/15/2023	2,960,000 shares	$2.96 million	-9.5%	N/A	3.8	$1.00
10/31/2023	3,270,000 shares	$3.47 million	-24.7%	N/A	4.1	$1.06
10/15/2023	4,340,000 shares	$5.25 million	+77.9%	N/A	5.4	$1.21
9/30/2023	2,440,000 shares	$3.59 million	-2.4%	N/A	3	$1.47
9/15/2023	2,500,000 shares	$3.58 million	+4.6%	N/A	2.7	$1.43
8/31/2023	2,390,000 shares	$3.99 million	+11.7%	N/A	2.5	$1.67
8/15/2023	2,140,000 shares	$3.66 million	+7.5%	N/A	2.1	$1.71
7/31/2023	1,990,000 shares	$4.80 million	-2.0%	N/A	1.9	$2.41
7/15/2023	2,030,000 shares	$5.14 million	-6.5%	N/A	1.9	$2.53
6/30/2023	2,170,000 shares	$5.45 million	+6.9%	N/A	2.1	$2.51
6/15/2023	2,030,000 shares	$3.35 million	-12.9%	N/A	1.9	$1.65
5/31/2023	2,330,000 shares	$3.84 million	-28.3%	N/A	2	$1.65
5/15/2023	3,250,000 shares	$5.72 million	-11.0%	N/A	2.6	$1.76
4/30/2023	3,650,000 shares	$6.06 million	-14.7%	N/A	2.8	$1.66
4/15/2023	4,280,000 shares	$6.12 million	+3.1%	N/A	3	$1.43
3/31/2023	4,150,000 shares	$6.18 million	-5.7%	N/A	2.7	$1.49
3/15/2023	4,400,000 shares	$7.22 million	-21.7%	N/A	4.4	$1.64
2/28/2023	5,620,000 shares	$11.13 million	+4.9%	N/A	5.6	$1.98
2/15/2023	5,360,000 shares	$11.36 million	-10.2%	N/A	5.6	$2.12
1/31/2023	5,970,000 shares	$14.33 million	-13.9%	N/A	5.5	$2.40
1/15/2023	6,930,000 shares	$10.67 million	-2.0%	N/A	3.6	$1.54
Unveiled: NVIDIA’s "Secret Royalty" Program (Ad) Did you know that there's an investment that will give you the opportunity to collect "royalties" every time Nvidia makes a chip? Click Here to learn how to get in now >>>
12/30/2022	7,070,000 shares	$9.90 million	-1.7%	N/A	1.8	$1.40
12/15/2022	7,190,000 shares	$8.63 million	+2.1%	N/A	1.9	$1.20
11/30/2022	7,040,000 shares	$9.43 million	+0.7%	N/A	1.9	$1.34
11/15/2022	6,990,000 shares	$10.35 million	-0.9%	N/A	1.9	$1.48
10/31/2022	7,050,000 shares	$12.48 million	+92.6%	N/A	2.1	$1.77
10/15/2022	3,660,000 shares	$36.71 million	+418.7%	N/A	1.2	$10.03
9/30/2022	705,600 shares	$2.23 million	-20.9%	N/A	0.8	$3.16
9/15/2022	892,200 shares	$3.57 million	-3.2%	N/A	5.5	$4.00
8/31/2022	921,200 shares	$4.10 million	-5.3%	N/A	4.4	$4.45
8/15/2022	972,600 shares	$5.34 million	-7.4%	N/A	1.4	$5.49
7/31/2022	1,050,000 shares	$3.72 million	-9.5%	N/A	1.4	$3.54
7/15/2022	1,160,000 shares	$4.55 million	+3.6%	N/A	1.5	$3.92
6/30/2022	1,120,000 shares	$3.89 million	-41.1%	N/A	1.5	$3.47
6/15/2022	1,900,000 shares	$6.46 million	+22.6%	N/A	2.5	$3.40
5/31/2022	1,550,000 shares	$9.61 million	+25.0%	N/A	2.2	$6.20
5/15/2022	1,240,000 shares	$7.25 million	+8.8%	N/A	4.9	$5.85
4/30/2022	1,140,000 shares	$7.72 million	-20.3%	N/A	5	$6.77
4/15/2022	1,430,000 shares	$14.89 million	-5.3%	7.0%	5.6	$10.41
3/31/2022	1,510,000 shares	$17.06 million	-5.0%	7.5%	6.3	$11.30
3/15/2022	1,590,000 shares	$16.46 million	+17.8%	7.9%	5.6	$10.35
2/28/2022	1,350,000 shares	$15.73 million	-4.3%	6.7%	4.6	$11.65
2/15/2022	1,410,000 shares	$18.65 million	+13.7%	7.5%	5.4	$13.23
1/31/2022	1,240,000 shares	$14.62 million	+6.0%	6.6%	4.7	$11.79
1/15/2022	1,170,000 shares	$13.86 million	-14.0%	N/A	5.4	$11.85
12/31/2021	1,360,000 shares	$13.02 million	+29.5%	7.2%	6.4	$9.57
12/15/2021	1,050,000 shares	$9.29 million	+7.4%	5.8%	4.9	$8.85
11/30/2021	978,000 shares	$8.34 million	+1.8%	5.5%	4.8	$8.53
11/15/2021	961,100 shares	$8.89 million	+6.1%	5.4%	4.7	$9.25
10/29/2021	905,500 shares	$8.44 million	+4.2%	5.1%	4.6	$9.32
10/15/2021	868,700 shares	$7.53 million	-9.5%	4.9%	4	$8.67
9/30/2021	959,700 shares	$8.49 million	+3.2%	5.4%	3.6	$8.85
9/15/2021	930,400 shares	$8.89 million	-3.3%	5.3%	4.1	$9.55
8/31/2021	962,400 shares	$9.48 million	-32.2%	5.4%	4.1	$9.85
8/13/2021	1,420,000 shares	$13.43 million	-13.4%	8.0%	6.3	$9.46
7/30/2021	1,640,000 shares	$14.48 million	-5.8%	10.3%	7.3	$8.83
7/15/2021	1,740,000 shares	$16.25 million	+12.3%	10.9%	8.5	$9.34
6/30/2021	1,550,000 shares	$19.00 million	+6.9%	11.7%	10.2	$12.26
6/15/2021	1,450,000 shares	$19.00 million	-2.0%	11.0%	10.9	$13.10
5/28/2021	1,480,000 shares	$19.99 million	-0.7%	11.2%	10.9	$13.51
5/14/2021	1,490,000 shares	$19.52 million	+0.7%	N/A	9.2	$13.10
4/30/2021	1,480,000 shares	$22.82 million	+2.1%	N/A	6.5	$15.42
4/15/2021	1,450,000 shares	$21.05 million	+2.1%	N/A	6.4	$14.52
3/31/2021	1,420,000 shares	$20.80 million	+52.4%	N/A	6.1	$14.65
3/15/2021	931,800 shares	$15.15 million	-28.9%	N/A	3.5	$16.26
2/26/2021	1,310,000 shares	$20.49 million	+45.9%	N/A	5.1	$15.64
2/12/2021	897,700 shares	$18.38 million	-4.8%	N/A	3.2	$20.47
1/29/2021	942,700 shares	$15.76 million	+38.6%	N/A	4.1	$16.72
1/15/2021	680,000 shares	$12.25 million	-27.0%	N/A	2.8	$18.02
12/31/2020	931,700 shares	$15.29 million	+34.7%	N/A	3.6	$16.41
12/15/2020	691,900 shares	$12.97 million	-34.1%	N/A	2.4	$18.75
Unveiled: NVIDIA’s "Secret Royalty" Program (Ad) Did you know that there's an investment that will give you the opportunity to collect "royalties" every time Nvidia makes a chip? Click Here to learn how to get in now >>>
11/30/2020	1,050,000 shares	$18.43 million	+33.7%	N/A	3	$17.55
11/15/2020	785,500 shares	$14.85 million	+6.8%	N/A	1.7	$18.90
10/30/2020	735,200 shares	$12.58 million	+4.8%	N/A	1.5	$17.11
10/15/2020	701,800 shares	$13.27 million	-33.8%	N/A	1.1	$18.91
9/30/2020	1,060,000 shares	$19.68 million	+38.0%	N/A	1.7	$18.57
9/15/2020	768,100 shares	$13.76 million	+64.1%	N/A	1.2	$17.92
8/31/2020	468,200 shares	$7.51 million	+79.1%	N/A	0.8	$16.05
8/14/2020	261,400 shares	$5.18 million	+84.9%	N/A	0.5	$19.83
7/31/2020	141,400 shares	$2.43 million	-3.4%	N/A	0.3	$17.20
7/15/2020	146,400 shares	$1.77 million	+10.2%	1.8%	0.4	$12.11
6/30/2020	132,800 shares	$1.66 million	+129.8%	1.9%	0.4	$12.49
6/15/2020	57,800 shares	$643,314.00	-11.5%	0.9%	0.2	$11.13
5/29/2020	65,300 shares	$707,852.00	-55.3%	1.1%	0.3	$10.84
5/15/2020	146,100 shares	$1.44 million	+139.9%	3.2%	0.9	$9.85
4/30/2020	60,900 shares	$524,958.00	+25.6%	1.4%	0.6	$8.62
4/15/2020	48,500 shares	$363,265.00	-2.8%	1.3%	0.7	$7.49
3/31/2020	49,900 shares	$459,080.00	+25.7%	1.3%	2.2	$9.20
3/13/2020	39,700 shares	$258,050.00	-2.9%	1.3%	4.6	$6.50
2/28/2020	40,900 shares	$215,134.00	+7.9%	1.3%	1.4	$5.26
2/14/2020	37,900 shares	$308,127.00	+4.7%	1.2%	1.2	$8.13
1/31/2020	36,200 shares	$285,256.00	-32.2%	1.2%	1.1	$7.88
1/15/2020	53,400 shares	$465,648.00	-14.6%	1.7%	1.8	$8.72
12/31/2019	62,500 shares	$513,750.00	+30.2%	2.0%	2.2	$8.22

IMUX Short Interest - Frequently Asked Questions

What is Immunic's current short interest?: Short interest is the volume of Immunic shares that have been sold short but have not yet been closed out or covered. As of August 31st, investors have sold 2,330,000 shares of IMUX short. Learn More on Immunic's current short interest.
What is a good short interest ratio for Immunic?: The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IMUX shares currently have a short interest ratio of 8.0. Learn More on Immunic's short interest ratio.
Is Immunic's short interest increasing or decreasing?: Immunic saw a decrease in short interest during the month of August. As of August 31st, there was short interest totaling 2,330,000 shares, a decrease of 7.5% from the previous total of 2,520,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.
How does Immunic's short interest compare to its competitors?: Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Immunic: Ovid Therapeutics Inc. (1.23%), TherapeuticsMD, Inc. (0.88%), Arcturus Therapeutics Holdings Inc. (21.78%), Eliem Therapeutics, Inc. (2.18%), Fulcrum Therapeutics, Inc. (12.97%), Valneva SE (0.07%), Altimmune, Inc. (31.03%), Neurogene Inc. (17.70%), Acelyrin, Inc. (11.22%), Oculis Holding AG (0.08%),

Which stocks are the most shorted right now?: As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.11 billion), Canadian Natural Resources Limited ($4.04 billion), Suncor Energy Inc. ($3.19 billion), Aptiv PLC ($2.56 billion), Paychex, Inc. ($2.48 billion), Cencora, Inc. ($2.28 billion), Onsemi ($2.08 billion), Moderna, Inc. ($1.98 billion), Tractor Supply ($1.93 billion), and International Paper ($1.93 billion). View all of the most shorted stocks.
What does it mean to sell short Immunic stock?: Short selling IMUX is an investing strategy that aims to generate trading profit from Immunic as its price is falling. IMUX shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.
How does a short squeeze work against Immunic?: A short squeeze for Immunic occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of IMUX, which in turn drives the price of the stock up even further.
How often is Immunic's short interest reported?: Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IMUX, twice per month. The most recent reporting period available is August, 31 2024.